Diagnostic Imaging's A Look Ahead: April 5, 2021, to April 9, 2021
Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
Much has been reported recently about the low utilization rate of low-dose CT lung cancer screening. In a new study published in the Journal of the American College of Radiology, investigators explored the factors behind low adherence to annual screening, as well as what might influence patients to follow the screening schedule. Look for a detailed story later this week.
For more lung cancer screening coverage, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Chest CT is routinely used to provide a great deal of information about the heart or to screen for lung cancer, but it can offer up valuable data about other conditions, as well. In an article on a study that will be released later this week, we will outline how the scan can be used to shed light on risks faced by patients with other lung-related conditions. Keep your eye out for the story.
For more coverage chest CT, click here.
Digital breast tomosynthesis is now widely used and is known for its better detection rate and efficacy in women with dense breast tissue. But, it turns out the scan offers additional benefits in detecting some of the most aggressive forms of breast cancer. Watch out for an article later this week that will discuss the details of a new study released this week.
For additional digital breast tomosynthesis coverage, click here.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.
